Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same

A technology of actin and protein binding, applied in DNA/RNA fragments, pharmaceutical formulations, recombinant DNA technology, etc., can solve problems that have not been fully clarified, and achieve the effect of inhibiting tumor spread, invasion and infiltration

Active Publication Date: 2013-01-02
TIANJIN MEDICAL UNIV CANCER HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, the molecular mechanism of invasion and invasion of malignant glioma has not been fully clarified

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same
  • Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same
  • Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Sources of experimental materials:

[0027] Human malignant glioma cell line LN-229 was provided by the University of Texas MD Anderson Cancer Center, the chemotaxis chamber was purchased from Neuro Probe, EGF was purchased from Peprotech, the intersectin1 antibody was from Abcam, and G418 was purchased from Invitrogen company.

[0028] 2. Design and synthesis of Girdin-siRNA

[0029] Design specific intersectin1-siRNA according to the siRNA design software provided by Ambion on the Internet, and synthesize the following templates by Shanghai Gemma Pharmaceutical Technology Co., Ltd., with BamH I and Bbs I restriction sites at both ends, and siRNA action sites:

[0030] 5'-GAAGGAGAGGCAACTGGAT - 3'.

[0031] 3. Preparation of Girdin-siRNA fusion expression vector

[0032] The expression vector pGPU6 / GFP / Neo vector has a linear structure, with sticky ends of BamH I and Bbs I restriction sites at both ends. The synthesized Girdin-siRNA was annealed, connected into t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, a fusion expression vector thereof and medical application of the same, belonging to the field of biological pharmacy. The invention designs a segment of cytoskeletal binding protein siRNA interfering sequence, and synthesizes the fusion expression vector of the cytoskeletal binding protein siRNA interfering sequence; after the fusion expression vector is transfected into a human glioma cell line, the fusion expression vector can specifically degrade the cytoskeletal binding protein messenger RNA (mRNA) complementary to the fusion expression vector to reduce the expression of the cytoskeletal binding protein in the human glioma cells; and the fusion expression vector can effectively inhibit the migration, adhesion and invasion abilities of the human glioma cells, has an effect on inhibiting the human glioma cellular infiltration and metastasis, and provides a feasible technical means for gene therapy for tumor patients.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a cell actin binding protein siRNA interference fragment for inhibiting glioma cell infiltration and spread, its fusion expression vector and the medical application of the expression vector. Background technique [0002] Post-transcriptional gene silencing is an evolutionary defense mechanism against transcriptomes and RNA viruses that arose before the divergence of plants and animals. In 1998, Andrew Fire of the Carnegie Institute of Washington and Craig Mello of the University of Massachusetts Cancer Center injected double-stranded dsRNA (double-stranded RNA) into nematodes for the first time, which induced gene silencing stronger than individual injections of the sense and antisense strands. This suppression of specific gene expression triggered by dsRNA is called RNA interference (RNA interference RNAi). [0003] RNA interference is fragment-specific gene silencing caused by do...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113C12N15/85A61K48/00A61P35/00A61P35/04
Inventor 马勇杰谷峰王静
Owner TIANJIN MEDICAL UNIV CANCER HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com